Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats

Cardiovascular Research

Volumn 79, Issue 3, 2008, Pages 492-499

  Shuvy, Mony ^a   Abedat, Suzan ^a   Beeri, Ronen ^a   Danenberg, Haim D ^a   Planer, David ^a   Ben Dov, Iddo Z ^a   Meir, Karen ^a   Sosna, Jacob ^a   Lotan, Chaim ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Aortic valve; Calcification; NF B pathway; Renal failure; Reversibility

Indexed keywords

CALCIUM; CD68 ANTIGEN; CREATININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOPONTIN; PARATHYROID HORMONE; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; AORTA VALVE CALCIFICATION; ARTICLE; CALCIFICATION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET; DOWN REGULATION; ECHOCARDIOGRAPHY; ENZYME ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOLOGY; HOMEOSTASIS; HYPERPARATHYROIDISM; INFLAMMATION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MINERAL METABOLISM; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOBLAST; PARATHYROID HORMONE BLOOD LEVEL; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RAT; UREMIA;

ADENINE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AORTIC VALVE; BLOTTING, WESTERN; CALCINOSIS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CREATININE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER, COLOR; HEART VALVE DISEASES; HYPERPARATHYROIDISM, SECONDARY; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; NF-KAPPA B; OSTEOCALCIN; OSTEOPONTIN; PARATHYROID HORMONE; PHOSPHATES; PHOSPHORUS, DIETARY; RANK LIGAND; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UREMIA;

EID: 48749098552     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn088     Document Type: Article

References (38)

1. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-3326.
2. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-2184.
3. Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007;115:377-386.
4. Kaden JJ, Dempfle CE, Grobholz R, Fischer CS, Vocke DC, Kiliç R et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005;14:80-87.
5. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden M, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994;23:1162-1170.
6. Faggiano P, Antonini-Canterin F, Baldessin F, Lorusso R, D'Aloia A, Cas LD. Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound 2006;4:27.
7. Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Gonçalves F et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007;49:554-561.
8. Partridge NC, Li X, Qin L. Understanding parathyroid hormone action. Ann NY Acad Sci 2006;1068:187-193.
9. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001;85:635-638.
10. Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003;41:1211-1217.
11. Drolet MC, Roussel E, Deshaies Y, Couet J, Arsenault M. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. J Am Coll Cardiol 2006;47:850-855.
12. Levi R, Ben-Dov IZ, Lavi-Moshayoff V, Dinur M, Martin D, Naveh-Many T et al. Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the transacting factor AUF1. J Am Soc Nephrol 2006;17:107-112.
13. Slatopolsky R, Finch J, Denga M, Ritter C, Zhong M, Dusso A et al. Phosphate restriction prevents parathyroid cell growth in uremic rats. High phosphate directly stimulates PTH secretion in vitro. J Clin invest 1995;96:327-333.
14. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832.
15. Catty D. Antibodies: a practical approach. In: Rickwood HB, ed. Practical Approach Series, Vol. 1. Oxford, MA, USA: IRL Press; 1988.
16. ImageJ: Image processing and analysis in Java. Provider: NIH Edition: 1.29.
17. Feuchtner GM, Muller S, Grander W, Alber HF, Bartel T, Friedrich GJ et al. Aortic valve calcification as quantified with multislice computed tomography predicts short-term clinical outcome in patients with asymptomatic aortic stenosis. J Heart Valve Dis 2006;15:494-498.
18. Cuniberti LA, Stutzbach PG, Guevara E, Yannarelli GG, Laguens RP, Favaloro RR. Development of mild aortic valve stenosis in a rabbit model of hypertension. J Am Coll Cardiol 2006;47:2303-2309.
19. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002;105:2660-2665.
20. Persy V, Postnov A, Neven E, Dams G, De Broe M, D'Haese P et al. High-resolution X-ray microtomography is a sensitive method to detect vascular calcification in living rats with chronic renal failure. Arterioscler Thromb Vasc Biol 2006;26:2110-2116.
21. Ketteler M, Giachelli C. Novel insights into vascular calcification. Kidney Int Suppl 2006;105:S5-S9.
22. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the ADQI Group. Crit Care 2004;8:R204-R212.
23. Malergue MC, Urena P, Prieur P, Guedon-Rapoud C, Petrover M. Incidence and development of aortic stenosis in chronic hemodialysis. An ultrasonographic and biological study of 112 patients. Arch Mal Coeur Vaiss 1997;90:1595-1601.
24. Kume T, Kawamoto T, Akasaka T, Watanabe N, Toyota E, Neishi Y et al. Rate of progression of valvular aortic stenosis in patients undergoing dialysis. J Am Soc Echocardiogr 2006;19:914-918.
25. Chen NX, Moe SM. Uremic vascular calcification. J Invest Med 2006;54:380-384.
26. Niederle B, Stefenelli T, Glogar D, Woloszczuk W, Roka R, Mayr H. Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study. Surgery 1990;108:1052-1057.
27. Malluche HH, Koszewski N, Monier-Faugere MC, Williams JP, Mawad H. Influence of the parathyroid glands on bone metabolism. Eur J Clin Invest 2006;36:23-33.
28. Lian JB, Stein GS. Runx2/Cbfa1: a multifunctional regulator of bone formation. Curr Pharm Des 2003;9:2677-2685.
29. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. N Engl J Med 1995;332:305-311.
30. Griveas I, Visvardis G, Papadopoulou D, Mitsopoulos E, Kyriklidou P, Manou E et al. Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis. Renal Fail 2005;27:275- 278.
31. Angelini D, Carlini A, Giusti R, Grassi R, Mei E, Fiorini I et al. Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy. Artif Organs 1993;17:73-75.
32. Wang A, Woo J, Wang M, Sea MM, Ip R, Li PK et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2001;12:1927-1936.
33. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001;15:2579-2985.
34. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factorkappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001;79:243-253.
35. Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD et al. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 2004;19:235-244.
36. Kaden JJ, Bickelhaupt S, Grobholz R, Haase KK, Sarikoç A, Kiliç R et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 2004;36:57-66.
37. Buckley KA, Hipskind RA, Gartland A, Bowler WB, Gallagher JA. Adenosine triphosphate stimulates human osteoclast activity via up-regulation of osteoblast-expressed receptor activator of nuclear factor-kappa B ligand. Bone 2002;31:582-590.
38. Osman L, Chester AH, Amrani M, Yacoub MH, Smolenski RT. A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin. Circulation 2006;114:I566-I572.